Variant report

Variant	nsv869744
Chromosome Location	chr9:26256188-26435849
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr9:25963971..25964744-chr9:26326247..26327016,2	MCF-7	breast:
2	chr9:25964124..25964728-chr9:26326171..26327079,3	MCF-7	breast:
3	chr9:26326443..26327103-chr9:26862889..26863559,2	MCF-7	breast:

Extended variants
information (count: 3869 )
Associated
traits (count: 120 )

Variant overlapped rSNPs/rCNVs (count:3869 , 50 per page) page: 1 2 3 4 5 6 7 ... 78

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs562189260	chr9:26256208-26256209	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs473367	chr9:26256238-26256239	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs368661199	chr9:26256265-26256266	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs566332118	chr9:26256298-26256299	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs548812565	chr9:26256314-26256315	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs551918280	chr9:26256337-26256338	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs570177324	chr9:26256359-26256360	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs182871223	chr9:26256369-26256370	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs555970092	chr9:26256390-26256391	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs187974759	chr9:26256410-26256411	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs571214535	chr9:26256413-26256414	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs145659067	chr9:26256449-26256450	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs538507900	chr9:26256450-26256451	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs571967795	chr9:26256487-26256488	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs145430958	chr9:26256491-26256492	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs553642981	chr9:26256493-26256494	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs148800573	chr9:26256514-26256515	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs576132494	chr9:26256539-26256540	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs191925098	chr9:26256561-26256562	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs12350133	chr9:26256650-26256651	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs565584283	chr9:26256658-26256659	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs529412371	chr9:26256697-26256698	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs567328037	chr9:26256713-26256714	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs541398044	chr9:26256756-26256757	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs389327	chr9:26256782-26256783	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs554400035	chr9:26256783-26256784	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs374502455	chr9:26256808-26256809	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs377227355	chr9:26256810-26256811	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs142379941	chr9:26256814-26256815	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs151306487	chr9:26256846-26256847	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs564044694	chr9:26256859-26256860	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs531002123	chr9:26256892-26256893	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs549211922	chr9:26256895-26256896	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs576051583	chr9:26256917-26256918	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs147298971	chr9:26256950-26256951	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs35007276	chr9:26256959-26256960	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs529223939	chr9:26256960-26256961	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs567768473	chr9:26256973-26256974	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs184484871	chr9:26256990-26256991	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs546952105	chr9:26257014-26257015	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs565356136	chr9:26257027-26257028	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs539444728	chr9:26257036-26257037	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs189168976	chr9:26257057-26257058	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs576335076	chr9:26257083-26257084	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs536802153	chr9:26257105-26257106	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs555612184	chr9:26257123-26257124	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs574150104	chr9:26257134-26257135	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs140886686	chr9:26257199-26257200	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs572433571	chr9:26257207-26257208	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs192237840	chr9:26257235-26257236	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:120)

Disease	PMID	Source
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic myeloid leukemia	21384125	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Cancer	22183965	CNVD
Acute myeloid leukemia	19651601	CNVD
Coronary Disease	20032323	CNVD
Squamous cell cancer	20885788	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21732550	CNVD
Gastric cancer	22539939	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Metastatic melanoma	18483359	CNVD
Non-small cell lung cancer	20864512	CNVD
Cervical cancer	21062161	CNVD
Acute myeloid leukemia	16864856	CNVD
Glioblastoma	17090523	CNVD
Lung cancer	16773561	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16774939	CNVD
Bladder cancer	19088036	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	16977458	CNVD
Glioblastoma multiforme	17369134	CNVD
Chagasic megaesophagus	20163722	CNVD
Melanoma	19566914	CNVD
Squamous cell cancer	19047905	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Hodgkin''s lymphoma	18179710	CNVD
Adenoid cystic carcinoma	18332873	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Acute myeloid leukemia	21251322	CNVD
Oral cancer	21386901	CNVD
Breast cancer	21858162	CNVD
Pancreatic cancer	21811587	CNVD
Barrett''s syndrome	19417022	CNVD
Myelofibrosis	22110671	CNVD
Urothelial cell carcinoma	18451213	CNVD
polycythaemia	22829968	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20967226	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Glioblastoma multiforme	21525872	CNVD
Renal cell carcinoma	21215367	CNVD

Chromatin state (count:348 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:26249400-26256800	Weak transcription	Hela-S3	cervix
2	chr9:26256000-26256400	Enhancers	NHEK	skin
3	chr9:26256200-26256800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
4	chr9:26256400-26259600	Weak transcription	NHEK	skin
5	chr9:26256800-26259400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
6	chr9:26256800-26260200	Enhancers	Hela-S3	cervix
7	chr9:26259200-26260000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
8	chr9:26259200-26260000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
9	chr9:26259200-26260800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
10	chr9:26259200-26262800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
11	chr9:26259200-26262800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
12	chr9:26259200-26263200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
13	chr9:26259400-26259800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr9:26259400-26260000	Enhancers	A549	lung
15	chr9:26259400-26260000	Enhancers	HUVEC	blood vessel
16	chr9:26259400-26260200	Enhancers	NH-A	brain
17	chr9:26259400-26262800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
18	chr9:26259400-26262800	Enhancers	HMEC	breast
19	chr9:26259600-26260000	Enhancers	Muscle Satellite Cultured Cells	--
20	chr9:26259600-26261800	Enhancers	HSMM	muscle
21	chr9:26259600-26261800	Enhancers	NHEK	skin
22	chr9:26259800-26260400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
23	chr9:26259800-26260800	Enhancers	HSMMtube	muscle
24	chr9:26259800-26263000	Enhancers	NHDF-Ad	bronchial
25	chr9:26260000-26260200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
26	chr9:26260000-26260400	Flanking Active TSS	Muscle Satellite Cultured Cells	--
27	chr9:26260000-26260400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
28	chr9:26260000-26260600	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
29	chr9:26260000-26260600	Flanking Active TSS	A549	lung
30	chr9:26260000-26260800	Flanking Active TSS	HUVEC	blood vessel
31	chr9:26260200-26260400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
32	chr9:26260200-26260400	Enhancers	NHLF	lung
33	chr9:26260200-26260600	Flanking Active TSS	Hela-S3	cervix
34	chr9:26260200-26260600	Flanking Active TSS	NH-A	brain
35	chr9:26260200-26260800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
36	chr9:26260400-26261400	Weak transcription	NHLF	lung
37	chr9:26260400-26261600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
38	chr9:26260400-26261600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
39	chr9:26260400-26261800	Enhancers	Muscle Satellite Cultured Cells	--
40	chr9:26260400-26262400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
41	chr9:26260600-26261200	Enhancers	NH-A	brain
42	chr9:26260600-26261400	Enhancers	Hela-S3	cervix
43	chr9:26260600-26261600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
44	chr9:26260600-26261800	Enhancers	A549	lung
45	chr9:26260800-26261200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
46	chr9:26260800-26261200	Weak transcription	HSMMtube	muscle
47	chr9:26260800-26261800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
48	chr9:26260800-26264000	Enhancers	HUVEC	blood vessel
49	chr9:26261200-26261800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
50	chr9:26261200-26262400	Enhancers	HSMMtube	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links